Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse
Joseph T. Coyle, W. Brad Ruzicka, Darrick T. Balu
American Journal of Psychiatry (2020) Vol. 177, Iss. 12, pp. 1119-1128
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Steven M. Paul, Samantha E. Yohn, Michael Popiolek, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 9, pp. 611-627
Closed Access | Times Cited: 81
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
Rajiv Tandon, Henry A. Nasrallah, Schahram Akbarian, et al.
Schizophrenia Research (2023) Vol. 264, pp. 1-28
Open Access | Times Cited: 60
Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
Michel Cuénod, Pascal Steullet, Jan-Harry Cabungcal, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 4, pp. 1886-1897
Open Access | Times Cited: 79
Stress induces behavioral abnormalities by increasing expression of phagocytic receptor MERTK in astrocytes to promote synapse phagocytosis
Youkyeong Gloria Byun, Namshik Kim, Gyuri Kim, et al.
Immunity (2023) Vol. 56, Iss. 9, pp. 2105-2120.e13
Open Access | Times Cited: 40
d-Amino acids: new clinical pathways for brain diseases
Isis Nem de Oliveira Souza, Robin Roychaudhuri, Jacqueline de Belleroche, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1014-1028
Open Access | Times Cited: 28
Mechanisms of NMDA receptor regulation
Laétitia Mony, Pierre Paoletti
Current Opinion in Neurobiology (2023) Vol. 83, pp. 102815-102815
Open Access | Times Cited: 28
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Paul J. Harrison, David M. Bannerman
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3568-3572
Open Access | Times Cited: 24
A Critical Reappraisal of Haloperidol for Delirium Management in the Intensive Care Unit: Perspective from Psychiatry
Shixie Jiang, Matthew Gunther
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 438-438
Open Access | Times Cited: 1
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
Arianna De Rosa, Andrea Fontana, Tommaso Nuzzo, et al.
Schizophrenia (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 33
Novel Compounds in the Treatment of Schizophrenia—A Selective Review
Eva-Maria Tsapakis, Kalliopi Diakaki, Apostolos Miliaras, et al.
Brain Sciences (2023) Vol. 13, Iss. 8, pp. 1193-1193
Open Access | Times Cited: 18
Multiple genes in a single GWAS risk locus synergistically mediate aberrant synaptic development and function in human neurons
Siwei Zhang, Hanwen Zhang, Marc P. Forrest, et al.
Cell Genomics (2023) Vol. 3, Iss. 9, pp. 100399-100399
Open Access | Times Cited: 17
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
Ali Azargoonjahromi
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 471-493
Closed Access | Times Cited: 7
Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
Lena Palaniyappan, Min Tae M Park, Peter Jeon, et al.
Antioxidants (2021) Vol. 10, Iss. 11, pp. 1703-1703
Open Access | Times Cited: 36
Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation
Nam-Shik Kim, Zhexing Wen, Jing Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia
Deborah K. Park, Samuel Petshow, Margarita Anisimova, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105772-105772
Open Access | Times Cited: 19
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia
Martina Garofalo, Giuseppe De Simone, Zoraide Motta, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia
Ruri Okubo, Motohiro Okada, Eishi Motomura
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1128-1128
Open Access | Times Cited: 4
Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning
Juan M. Uehara, Mariano Acosta, Estefanía P. Bello, et al.
Neuropsychopharmacology (2025)
Closed Access
Esquizofrenia: prevalência, diagnóstico e avanços no tratamento
Carlos Walmyr de Mattos Oliveira, Taiana Mara Roma, Leonardo Gomes Moreira, et al.
Caderno Pedagógico (2025) Vol. 22, Iss. 1, pp. e13486-e13486
Closed Access
Novel Treatments for Schizophrenia
Steven M. Paul, Alan Breier
Oxford University Press eBooks (2025), pp. 231-246
Closed Access
An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data
Chuyi Zhang, Xiao Xiao, Zhuohua Zhang, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 95-112
Closed Access | Times Cited: 24
Future Perspectives of NMDAR in CNS Disorders
Toni Capó, Joan Biel Rebassa, Iu Raïch, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 877-877
Open Access
IUPHAR Review: Computational Psychiatry 2.0. A new tool for Supporting Combination therapy of Psychopharmacology with Neuromodulation in Schizophrenia
Hugo Geerts
Pharmacological Research (2025), pp. 107718-107718
Open Access
d‐amino acids: new functional insights
Loredano Pollegioni, Nataša Kuštrimović, Luciano Piubelli, et al.
FEBS Journal (2025)
Open Access
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia
Kira Griffiths, Sophie E Smart, Gareth J. Barker, et al.
Schizophrenia Research (2023) Vol. 260, pp. 152-159
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top